A Potent and Safe H₂O₂ Fumigation Approach

References

1. 1.↵
   1. Halsen G,
   2. Bodenschatz W

   . Raumdesinfektion mit Formaldehyd. Berufsgenossenschaft für Gesundheitsdienst und Wohlfahrtspflege (BGW), Nr. GP3, BGW, D-22089 Hamburg, Germany, June 2009.
2. 2.↵
   Technical Roules for Hazardous Products 522 (Technische Regeln für Gefahrenstoffe 522, TRGS 522), Room Disinfection using Formaldehyde; June 1992; last change: refer to: Bundesarbeitsblatt (BArbBl) edition 9/2001. Germany.
3. 3.↵
   1. Schaal H,
   2. Schulze-Röbbecke R,
   3. Thaneiser M,
   4. Glück W

   . Sterilisation von HEPA-Filtern in Sicherheitswerkbänken der Klasse 2 mittels Formaldehydbegasung. Hygiene Medizin 2009, 34 (7–8), 282–286.

   OpenUrl
4. 4.↵
   1. Wallhäuser KH

   . Praxis der Sterilisation—Desinfektion—Konservierung, 5^th ed.; Georg Thieme Verlag: Stuttgart, New York, 1995; pp 586.
5. 5.↵
   1. Riniker HP

   . Das Dampf-, Ozon-, Luftverfahren (DOL) zur Desinfektion von Oberflächen und Räumen. Concept Seminar “Gasförmige Sterilisations- und Dekontaminationsverfahren,”, March 19 and 20, 1996, Darmstadt, Germany.
6. 6.↵
   1. Winter B,
   2. Contino A,
   3. O'Neill G

   . Chlorine dioxide Part 1. BioProcess International, Westborough, MA, USA; December 2005, pp 42–48.
7. 7.↵
   Dry Fog Minncare Cold Sterilant, Minntech Corporation: Minneapolis, MN, USA.
8. 8.↵
   Steris VHP 1000; Steris Corporation, Mentor, OH, USA.
9. 9.↵
   Clarus; Bioquell UK, Andover, Hampshire, UK.
10. 10.↵
    1. Reichenbacher D,
    2. Thanheiser M,
    3. Krüger D

    . Aktueller Stand zur Raumdekontamination mit gasförmigem Wasserstoffperoxid. Hygiene & Medizin 2010, 35 (6), 204–208.

    OpenUrl
11. 11.↵
    1. Sterchi AC

    . Hydrogen Peroxide in Pharmaceutical Isolators, Investigations about Behavior, Measurements and Effects. PhD Thesis No. 14044, ETH Zürich, 2001.
12. 12.↵
    Chapter 〈1116〉 Microbiological Evaluation of Clean Rooms. USP 34, General Information, U.S. Pharmacopeial Convention: Rockville, MD, December 2011.
13. 13.↵
    Chapter X. Laboratory Control, A. Environmental Monitoring. In Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing—cGMP; FDA: Rockville, MD, September 2004, pp 32–35.
14. 14.↵
    Pharmaceutical Inspection Convention, PIC/S; “Guide to Good Manufacturing Practice for Medicinal Products,” Annex 1: Clean Room and clean air device Monitoring, pp 3–4; Geneva, September 2009.
15. 15.↵
    1. Vanhecke P,
    2. Sigwarth V

    . Formulation Process Under Isolator, an Enhancement of the Isolated Process Chain. ISPE Washington Conference Paper, Barrier Isolation Forum, June 6–9, 2011.
16. 16.↵
    1. Wallhäuser KH

    . Praxis der Sterilisation—Desinfektion—Konservierung, 5^th ed.; Georg Thieme Verlag: Stuttgart, New York, 1995; pp 643– 645.
17. 17.↵
    1. Gomez M,
    2. Moldenhauer J

    . Chapter 12: Suitability of Biological Indicators for Vaporized Hydrogen Peroxide Decontamination. In Biological Indicators for Sterilization Processes; PDA: Bethesda, MD, 2009; pp 301–346.
18. 18.↵
    EU Risk Assessment Document. Hydrogen Peroxide (CAS No.: 7722-84-1), September 18, 1998.
19. 19.↵
    Test tubes for VHP, product no. 8101041; Drägerwerk AG & Co. KGaA, 23558 Lübeck, Germany.
20. 20.↵
    Chemical Indicators (CI), product no. 305, Steris Corporation, Mentor, OH, USA.
21. 21.↵
    1. Sigwarth V,
    2. Moirandat C

    . Development and quantification of H₂O₂ decontamination cycles. PDA J. Pharm. Sci. Technol. 2000, 54 (4), 286–304.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    GSK Bio, internal information (Wavre and Quebec sites experiences).